Evaluation of NHL subtypes, staging, and prognostic factors: A single-centric retrospective cohort study
While gender-based smoking and occupational disparities stand out, the prevalence of complete remission underscores treatment efficacy. Detecting challenges in advanced-stage diagnosis and incomplete treatments highlights the importance of timely intervention and comprehensive patient care. The absence of survival differences based on immunohistochemistry (IHC) subtypes suggests multifactorial influences on patient outcomes, motivating further investigation.
Authors
- Asifa Andleeb (ORCID: https://orcid.org/0000-0002-4975-1257)
- Burhan Wani
- Ulfat Ara Wani
- Gul Mohammad Bhat
- Umeek Jeelani
- Kaneez Fatima (ORCID: https://orcid.org/0000-0002-9146-7508)
- Sheikh Aejaz Aziz
- Shaheen Nazir Lone
Institutions
- Sher-i-Kashmir Institute of Medical Sciences (IN)
Publication Details
- Journal
- Journal of Cancer Research and Therapeutics
- Published
- 2025-01-01
- DOI
- https://doi.org/10.4103/jcrt.jcrt_25_24
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00